Defkalion offers testing of cold fusion reactors
UPDATED. The Greek company Defkalion has invited scientific and business organizations to test the core technology in its forthcoming energy products. The products are based on LENR – Low Energy Nuclear Reactions.
(Swedish version here)
In a press release on January 23, Defkalion has invited "internationally recognized and reputable scientific and business organizations" from now and two months ahead, to do independent testing with their own instruments on the reactors used in the Defkalion's forthvcoming energy device, "Hyperion".
The apparatus is according to Defkalion based on "Chemically Assisted Low Energy Nuclear Reactions caused by Nickel and Hydrogen Nuclei", a technology supposedly developed by the company after the termination of the agreement on production and distribution of Andrea Rossi's "E-cat" last summer.
Low Energy Nuclear Reactions, or LENR, is the term used in recent years instead of the more controversial "cold fusion", a new type of nuclear reactions that there is still little knowledge about.
Measurements will be made on the "bare" reactor without cooling, and according to Defkalion temperatures above 650°C will be reached, and also a power development that is far more than 20 times the input electrical power required to start the reaction (COP).
Defkalion describes a test method known as "Differential thermal analysis". The intention is to measure the difference between power development in a reactor loaded with fuel and one that is empty and only heated by the resistor needed to start the reaction, and then repeat the measurement after the reactors have been switched.
The description in the press release, however, is scant and partly incorrect.
In addition to power measurement, alpha and gamma radiation will be measured, and the reactors will be weighed, measured, and also opened.
Test protocols will be published before tests and the results may be published freely by invited evaluators.
Defkalion maintains that independent testing of the finished Hyperion products, which were presented in November 2011, will be made in the beginning of this year after certification of the products. Final products are supposed to be ready for market in 2012.
- - - -
Defkalion's answers in the forum at the company's website can be found through this link.
- - - -
Updated: On Tuesday it was also reported that the University of Bologna had terminated its relationship with Rossi regarding the paid research collaboration on the Ecat that was planned to begin since last summer. Ny Teknik reported on this collaboration in March 2011.
The University has now stated that the contract signed in June 2011 between the Department of Physics and Rossi was terminated due to failure to meet the conditions of the terms.
However, the University also pointed out that the Department of Physics is still available with its experience and its equipment to carry out independent measurements on the production of heat by the E-cat.
The University's Deputy President Dario Braga added that he is also open to new proposals with commissioned research on the technology.
Rossi told Ny Teknik that "the work of the University of Bologna has already started with meetings together with National Instruments to prepare the whole system analysis."
- - - -
READ MORE: Our complete coverage on Defkalion and on Rossi's E-cat can be found here.
Fakta Defkalion Green Technologies
Defkalion Green Technologies is a Greek company that originally had an agreement with Andrea Rossi on the manufacture and distribution of Rossi's "E-cat."
The agreement was terminated unilaterally by Rossi in August 2011, according to Rossi because Defkalion had not paid the agreed amount in time.
Just before the agreement was terminated, Defkalion supposedly began developing its own similar technology. The specifications for the forthcoming energy device, "Hyperion", was presented in December 2011.
Defkalion is owned by Cyprus-based Praxen Defkalion Green Technologies. CEO of Praxen, and the owners repesentative in Defkalion's board, is Alexandros Xanthoulis.
According to Defkalion, Praxen is owned by private investors in Canada and South America.
More articles about Defkalion are available here (in chronological order):